Indeed, SMARCB1-deficient MRT cells are unable to remove repressive PRC2-mediated histone modifications such as H3K27Me3 from tumour suppressor genes, for example CDKN2A (MIM #600160) [261]. This evidence concerns the gene SMARCB1 and neoplasm.